Homology Medicines, Inc. carries a market capitalization of 3.02M, placing it among publicly traded companies globally.
| Market Cap | 3.02M |
| Enterprise Value | N/A |
Homology Medicines, Inc.'s stock has declined approximately -94.75477% over the past 52 weeks. The 50-day moving average sits at 13.80, while the 200-day moving average is 16.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | -94.75477% |
| 50-Day Moving Average | 13.80 |
| 200-Day Moving Average | 16.10 |
| Average Volume (20 Days) | N/A |
Homology Medicines, Inc.'s most recent stock split took place on March 25, 2024 with a 18:1 split ratio.
| Last Split Date | 3/25/2024 |
| Split Ratio | 18:1 |